Biofrontera

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.53-$1.19
Market Cap
$9M
Shares Short
174,589

Financials

See more
Revenue (12 Mos)
$41.7M
Revenue Growth (YoY)
36.2%
Gross Profit (12 Mos)
$30.7M
Diluted EPS
-$1.04

News

See more

Yahoo Finance • 14 days ago

Biofrontera Inc. Q4 2025 Earnings Call Summary

Yahoo Finance • 14 days ago

Biofrontera (BFRI) Q4 2025 Earnings Transcript

Yahoo Finance • 4 months ago

Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities

Yahoo Finance • 4 months ago

Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT

About

CEO
Dr. Hermann Luebbert Ph.D.
Address
660 Main Street, Woburn, MA, United States, 01801
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-Time Employees
84